Impax Lab Revenue, Profits - IPXL Annual Income Statement

Add to My Stocks
$21.05 $0.25 (1.2%) IPXL stock closing price Mar 16, 2018 (Closing)

Fundamental analysis of IPXL stock involves analyzing its financial statements, apart from checking the Impax Lab stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Like any other income statement, the IPXL income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of -4.19% when compared to the same period in the past. The Impax Lab profit and loss statement for 2016 shows a net profit of $-472.03M. Profits for last year was $38.99M. Apart from this an investor should also check Impax Lab assets and Impax Lab free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Impax Lab Revenues or Net Sales
Cost Of Goods Sold (COGS)975.53M508.06M283.39M312.2M299.13M254.62M340.24M170.31M91.96M
Impax Lab Gross Profit
Research & Development Expense133.43M76.98M79.11M68.85M81.32M82.7M86.22M63.27M59.8M
Selling General & Admin Expense209.64M205.85M144.72M136.83M118.24M75.98M59.71M54.4M54.37M
Income Before Depreciation Depletion Amortization-494.18M69.56M88.81M-6.38M82.99M99.61M393.32M70.41M3.92M
Depreciation Depletion Amortization---------
Non Operating Income-40.7M17.06M1.78M153.74M--1.44M--28.34M
Interest Expense41.44M27.26M------2.59M
Impax Lab Pretax Income
Provision for Income Taxes-104.29M20.37M33.2M45.68M27.43M32.61M143.52M21M10.97M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-472.03M38.99M57.35M101.25M55.87M65.39M250.35M49.97M18.7M
Extraordinary Items & Discontinued Operations---------
Impax Lab Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS71.15M72.03M70.53M68.66M68.41M67.32M65.57M61.08M60.78M
Average Shares used to compute Basic EPS71.15M69.64M68.19M66.92M65.66M64.13M62.04M60.28M59.07M
Income Before Nonrecurring Items83.66M104.52M93.21M56.11M130.77M65.5M184.22M55.86M17.87M
Income from Nonrecurring Items-555.7M-65.52M-35.85M45.15M-74.9M-66.2M-5.8M-
Impax Lab Earnings Per Share Basic Net
Impax Lab Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items1.161.451.320.821.910.972.810.910.29
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Impax Lab stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the Impax Lab revenue chart, as isn't the case with Impax Lab indicates a sagging business. One needs to compare the YoY topline or sales growth of IPXL stock with its peers like AKRX stock and SUPN stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-472.03M for IPXL stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The IPXL financials along with Impax Lab historical stock prices provide a lot of details about the firm.

Impax Lab Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield